Warning letter
NX Generation Ltd.: warning letter of Jan 25, 2013
FDA warning letter UCM337546 · New York District Office
Key facts
| Reference number | UCM337546 |
|---|---|
| Company | NX Generation Ltd. |
| Subject | CGMP/Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements/Adulterated |
| Issue date | Jan 25, 2013 |
| Posted date | Jan 25, 2013 |
| Issuing office | New York District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 111, 111.260, 111.415, 111.515, 111.520, 111.70(d), 111.70(f), 111.255(b), 111.260(b), 111.260(c), 111.260(h), 111.260(k) and 6 more |
| Country | 3 |
| Inspection city | Hauppauge |
| Inspection ZIP | 11788 |
| Inspection start date | Jul 18, 2012 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: